There is growing interest in quantitative analysis of in vivo genetic toxicity dose-response data, and use of point-of-departure (PoD) metrics such as the benchmark dose (BMD) for human health risk assessment (HHRA). Currently, ...
Comparing BMD-Derived Genotoxic Potency Estimations Across Variants of the Transgenic Rodent Gene Mutation Assay
Environmental and Molecular Mutagenesis, 2017